Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biopharmaceutics and Drug Disposition is Scopus-indexed (Q2, CiteScore 4.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 0142-2782Verify ISSN ↗1099-081XVerify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: About US$3,800 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 80 / 191 | 58th | Q2 |
| Pharmacology (medical) | 126 / 278 | 54th | Q2 |
| Pharmacology | 175 / 328 | 46th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1979–present, best quartile Q2, CiteScore 4.2.
Biopharmaceutics and Drug Disposition is Q2 in Pharmaceutical Science (rank 80 of 191), Q2 in Pharmacology (medical) (rank 126 of 278) and Q3 in Pharmacology (rank 175 of 328), by CiteScore 2025.
Biopharmaceutics and Drug Disposition is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.2, which places it in quartile Q2 at the 58th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.540, quartile Q2, with an H-index of 72.
The publisher lists an article processing charge of about US$3,800 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biopharmaceutics and Drug Disposition is published by John Wiley and Sons Ltd. Its print ISSN is 0142-2782 and its online ISSN is 1099-081X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biopharmaceutics and Drug Disposition has an h-index of 79 and a 2-year mean of 1.49 citations per paper (OpenAlex). Its Scopus CiteScore is 4.2, quartile Q2. On 2-year citations it ranks #92 of 177 Scopus journals in Pharmaceutical Science.
Biopharmaceutics and Drug Disposition published 31 papers in 2025; its busiest recent year was 2017 with 65. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2022–2026), authors are most often from China (30.6%), Japan (21.9%) and United States (12.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.